Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;99(1):83-89.
doi: 10.1111/aos.14482. Epub 2020 Jul 9.

Long-term outcomes of vitrectomy for proliferative diabetic retinopathy

Affiliations

Long-term outcomes of vitrectomy for proliferative diabetic retinopathy

Vivian Schreur et al. Acta Ophthalmol. 2021 Feb.

Abstract

Purpose: To investigate the long-term outcomes of patients who underwent vitrectomy for proliferative diabetic retinopathy.

Methods: Cumulative incidences were calculated for low vision (<0.3), re-vitrectomy in the study eye and fellow eye vitrectomy. To identify potential prognostic factors that associate with these outcomes, we used multivariable Cox regression models.

Results: In a total of 217 patients, we found 1-, 5- and 10-year cumulative incidences of low vision in the study eye of 24%, 31% and 39%, respectively. For both eyes, these rates were, respectively, 10%, 14% and 14%. Low vision in both eyes was associated with higher age and worse contralateral visual acuity. The 1-, 5- and 10-year cumulative incidences for re-vitrectomy in the study eye were 16%, 27% and 27%, respectively, and for a vitrectomy in the fellow eye 24%, 40% and 54%, respectively. Re-vitrectomy of the study eye was associated with worse contralateral visual acuity, while vitrectomy of the fellow eye was associated with shorter diabetes duration, worse contralateral visual acuity, higher HbA1c level and worse diabetic retinopathy severity stage of the fellow eye.

Conclusion: Functional visual acuity in at least one eye was achieved or preserved in most patients. After 10 years, about a quarter of all patients underwent a re-vitrectomy, while more than half of the patients needed a vitrectomy of the fellow eye. Knowledge of these long-term outcomes is essential when counselling patients for a vitrectomy.

Keywords: diabetic retinopathy; long-term outcomes; vitrectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Course of follow‐up during the study period. Follow‐up completion was estimated by Kaplan–Meier survival analysis, censoring patients with complete follow‐up. Yearly cumulative incidence of deceased patients and patients lost to follow‐up were simultaneously plotted on the x‐axis.
Fig. 2
Fig. 2
Kaplan–Meier survival plots for (A) low vision and (B) the need for additional vitrectomy. The tables represent cumulative incidences of low vision and additional vitrectomy after 5 and 10 years with the corresponding 95% confidence intervals. Abbreviations: y = years.
Fig. 3
Fig. 3
Kaplan–Meier survival plots for (A) life and (B) survival of the crystalline lens. The tables represent cumulative incidences after 5 and 10 years with the corresponding 95% confidence intervals. Abbreviations: y = years. *Because the maximum follow‐up duration in the group with age >50 years was 8 years, the cumulative incidence at 8 year is given.

References

    1. Antonetti DA, Klein R & Gardner TW (2012): Diabetic retinopathy. N Engl J Med 366: 1227–1239. - PubMed
    1. Banerjee PJ, Moya R, Bunce C, Charteris DG, Yorston D & Wickham L (2016): Long‐term survival rates of patients undergoing vitrectomy for proliferative diabetic retinopathy. Ophthalmic Epidemiol 23: 94–98. - PubMed
    1. Blankenship GW & Machemer R (1985): Long‐term diabetic vitrectomy results. Report of 10 year follow‐up. Ophthalmology 92: 503–506. - PubMed
    1. Feng H & Adelman RA (2014): Cataract formation following vitreoretinal procedures. Clin Ophthalmol 8: 1957–1965. - PMC - PubMed
    1. Fisher DE, Jonasson F, Klein R, Jonsson PV, Eiriksdottir G, Launer LJ, Gudnason V & Cotch MF (2016): Mortality in older persons with retinopathy and concomitant health conditions: the age, gene/environment susceptibility‐Reykjavik study. Ophthalmology 123: 1570–1580. - PMC - PubMed